Mirum Pharmaceuticals (MIRM) Current Leases (2020 - 2024)
Historic Current Leases for Mirum Pharmaceuticals (MIRM) over the last 5 years, with Q4 2024 value amounting to $1.7 million.
- Mirum Pharmaceuticals' Current Leases rose 5480.07% to $1.7 million in Q4 2024 from the same period last year, while for Dec 2024 it was $1.7 million, marking a year-over-year increase of 5480.07%. This contributed to the annual value of $1.7 million for FY2024, which is 5480.07% up from last year.
- According to the latest figures from Q4 2024, Mirum Pharmaceuticals' Current Leases is $1.7 million, which was up 5480.07% from $1.5 million recorded in Q3 2024.
- Over the past 5 years, Mirum Pharmaceuticals' Current Leases peaked at $1.7 million during Q4 2024, and registered a low of $358000.0 during Q1 2024.
- In the last 5 years, Mirum Pharmaceuticals' Current Leases had a median value of $741500.0 in 2022 and averaged $850800.0.
- Examining YoY changes over the last 5 years, Mirum Pharmaceuticals' Current Leases showed a top increase of 5480.07% in 2024 and a maximum decrease of 6083.15% in 2024.
- Quarter analysis of 5 years shows Mirum Pharmaceuticals' Current Leases stood at $636000.0 in 2020, then increased by 11.79% to $711000.0 in 2021, then soared by 30.94% to $931000.0 in 2022, then increased by 18.58% to $1.1 million in 2023, then soared by 54.8% to $1.7 million in 2024.
- Its Current Leases was $1.7 million in Q4 2024, compared to $1.5 million in Q3 2024 and $1.1 million in Q2 2024.